Pixantrone Overview in Non-Hodgkin's Lymphoma to be Presented at 2009 Pan Pacific Lymphoma Conference

SEATTLE, June 16 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) today announced that Richard Van der Jagt, M.D. of Ottawa Hospital will be presenting an overview of pixantrone clinical studies in non-Hodgkin's lymphoma at the 2009 Pan Pacific Lymphoma Conference on Monday, June 22, 2009. The conference will be held from June 22-26, 2009 at the Fairmont Orchid hotel on the Big Island of Hawaii.

                           2009 Pan Pacific Lymphoma Conference
                      Pixantrone Presentation: Monday, June 22, 2009
                                     June 22-26, 2009
                                    The Fairmont Orchid
                                   1 North Kaniku Drive
                          Kohala Coast, Big Island, Hawaii  96743


  Media Contact:
  Dan Eramian
  T: 206.272.4343
  C: 206.854.1200
  E: deramian@ctiseattle.com
  www.CellTherapeutics.com/press_room

  Investors Contact:
  Ed Bell
  T: 206.282.7100
  Lindsey Jesch Logan
  T: 206.272.4347
  F: 206.272.4434
  E: invest@ctiseattle.com
  www.CellTherapeutics.com/investors

Source: Cell Therapeutics, Inc.

CONTACT: Dan Eramian, +1-206-272-4343, Cell, +1-206-854-1200, deramian@ctiseattle.com, or Investors, Ed Bell, +1-206-282-7100, or Lindsey Jesch Logan, +1-206-272-4347, or fax, +1-206-272-4434, invest@ctiseattle.com, all of Cell Therapeutics, Inc.

Web Site: http://www.celltherapeutics.com

Posted: June 2009

View comments

Hide
(web5)